Company / PP&E (Net)
Cartesian Therapeutics, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$12.2M
FY2025
5-year range
$2.1M / $12.2M
FY2021-FY2025
Trend
+22.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 8 years, ranging from $1M in FY2019 to $12M in FY2025.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +54.3%.
Improved from $2M to $12M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +63.4%
- 5-Year CAGR
- +54.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +54.3%, indicating consistent growth.
- In FY2025, pp&e (net) increased 22.9% year-over-year.
- Lowest pp&e (net) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.2M | +22.9% |
| FY2024 | $9.9M | +369.1% |
| FY2023 | $2.1M | -24.4% |
| FY2022 | $2.8M | +30.4% |
| FY2021 | $2.1M | +53.5% |
| FY2020 | $1.4M | +14.2% |
| FY2019 | $1.2M | -40.3% |
| FY2016 | $2.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026